14 julio 2015
A new study finds that peer influence among physicians can affect both trial and repeat prescription behavior of a risky new prescription drug. The study tracks prescriptions of a new drug over 17 months, and measures the discussion and patient referral connections among physicians in New York, Los Angeles, and San Francisco.img src=»http://feeds.feedburner.com/~r/sciencedaily/~4/9PQKGFobeEQ» height=»1″ width=»1″ alt=»»/
http://feeds.sciencedaily.com/~r/sciencedaily/~3/9PQKGFobeEQ/150714125405.htm
